KR101010547B1 - 알기닌아미드류를 함유하는 의약 제제 - Google Patents

알기닌아미드류를 함유하는 의약 제제 Download PDF

Info

Publication number
KR101010547B1
KR101010547B1 KR1020057017410A KR20057017410A KR101010547B1 KR 101010547 B1 KR101010547 B1 KR 101010547B1 KR 1020057017410 A KR1020057017410 A KR 1020057017410A KR 20057017410 A KR20057017410 A KR 20057017410A KR 101010547 B1 KR101010547 B1 KR 101010547B1
Authority
KR
South Korea
Prior art keywords
delete delete
solution
group
pharmaceutical composition
agatroban
Prior art date
Application number
KR1020057017410A
Other languages
English (en)
Korean (ko)
Other versions
KR20060002825A (ko
Inventor
가즈히코 오자키
마나미 히라미야
가츠요시 요시자와
다카시 야마다
다케시 히로카와
고우이치 스가와라
가츠노리 구루스
노보루 야마다
겐이치 가지하라
Original Assignee
미쓰비시 타나베 파마 코퍼레이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33027937&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR101010547(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 미쓰비시 타나베 파마 코퍼레이션 filed Critical 미쓰비시 타나베 파마 코퍼레이션
Publication of KR20060002825A publication Critical patent/KR20060002825A/ko
Application granted granted Critical
Publication of KR101010547B1 publication Critical patent/KR101010547B1/ko

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020057017410A 2003-03-20 2004-03-19 알기닌아미드류를 함유하는 의약 제제 KR101010547B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003077125 2003-03-20
JPJP-P-2003-00077125 2003-03-20

Publications (2)

Publication Number Publication Date
KR20060002825A KR20060002825A (ko) 2006-01-09
KR101010547B1 true KR101010547B1 (ko) 2011-01-24

Family

ID=33027937

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020057017410A KR101010547B1 (ko) 2003-03-20 2004-03-19 알기닌아미드류를 함유하는 의약 제제

Country Status (5)

Country Link
JP (1) JP3781308B2 (ja)
KR (1) KR101010547B1 (ja)
CN (1) CN100344624C (ja)
TW (1) TW200505422A (ja)
WO (1) WO2004083201A1 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006008696A (ja) * 2003-03-20 2006-01-12 Mitsubishi Pharma Corp アルギニンアミド類を含有する医薬製剤
JP5189980B2 (ja) * 2005-09-01 2013-04-24 バクスター・インターナショナル・インコーポレイテッド 可溶化剤として酸を含むアルガトロバン処方物
JP5438999B2 (ja) * 2009-03-19 2014-03-12 テルモ株式会社 アルガトロバン注射液製剤
CN102120026A (zh) * 2011-03-03 2011-07-13 天津市炜杰科技有限公司 以醇作为增溶剂的21(s)阿加曲班静脉注射液
CN102228426A (zh) * 2011-06-17 2011-11-02 天津市炜杰科技有限公司 以醇作为增溶剂的21(r)阿加曲班静脉注射液
CN104098647B (zh) * 2014-06-24 2017-12-08 安徽省逸欣铭医药科技有限公司 阿加曲班类似物及其制备方法和医药用途

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002241284A (ja) * 2001-02-16 2002-08-28 Towa Yakuhin Kk 全身投与用アルガトロバン注射液

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6431727A (en) * 1987-07-28 1989-02-02 Mitsubishi Chem Ind Dissolution of argininamide and drug composition containing argininamides
US5214052A (en) * 1987-07-28 1993-05-25 Mitsubishi Kasei Corporation Method for dissolving arginineamides and pharmaceutical compositions containing them
JP3530542B2 (ja) * 1992-03-18 2004-05-24 三菱化学株式会社 眼科用アルガトロバン製剤
FR2715566B1 (fr) * 1994-02-03 1996-03-08 Synthelabo Solutions aqueuses concentrées d'argatroban.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002241284A (ja) * 2001-02-16 2002-08-28 Towa Yakuhin Kk 全身投与用アルガトロバン注射液

Also Published As

Publication number Publication date
JP3781308B2 (ja) 2006-05-31
TWI327910B (ja) 2010-08-01
JPWO2004083201A1 (ja) 2006-06-22
KR20060002825A (ko) 2006-01-09
CN100344624C (zh) 2007-10-24
CN1761661A (zh) 2006-04-19
TW200505422A (en) 2005-02-16
WO2004083201A1 (ja) 2004-09-30

Similar Documents

Publication Publication Date Title
KR101053780B1 (ko) 도세탁셀을 함유하는 단일액상의 안정한 약제학적 조성물
JP6356873B2 (ja) タキサン系活性成分含有液体組成物及び液体製剤
US4942167A (en) Pharmaceutical compositions of piroxicam in aqueous solutions and process for their preparation
KR20080030024A (ko) 도세탁셀의 약제학적 액상제제
EP1386606B1 (en) Stable high-concentration injection containing pyrazolone derivative
JP2018516989A (ja) ヘッジホッグ阻害性化合物の送達のための局所的製剤及びその使用
TW202128210A (zh) 欣得泰乾粉注射劑穩定劑型
KR101010547B1 (ko) 알기닌아미드류를 함유하는 의약 제제
CA2798575C (en) Pharmaceutical composition of ibuprofen for injection
EP3984524A1 (en) Ornidazole injection and s-ornidazole injection
CN114028324B (zh) 钩藤碱温敏凝胶鼻腔给药制剂及制备方法
WO2023275157A1 (en) Aqueous, room-temperature stable rocuronium composition
JP3917820B2 (ja) オザグレルナトリウム含有注射液およびその安定化方法
JP2006008696A (ja) アルギニンアミド類を含有する医薬製剤
JP2010536906A (ja) Ｇ−ｃｓｆの液体製剤
CN100467024C (zh) 氯诺昔康注射用组合物及其制备方法
HU191538B (en) Process for producing pharmaceutical compositions containing acid additional salts of vinca-dimeres
CN100428937C (zh) 左西孟旦冷冻干燥组合物
EP3834825A1 (en) Busulfan composition, preparation method therefor and application thereof
UA75620C2 (en) Stable pharmaceutical form of paclitaxel and method for the preparation thereof
WO2017198224A1 (zh) 一种瑞马唑仑的药物组合物
JP2013216645A (ja) 炭酸ナトリウム含有シベレスタットナトリウム水和物凍結乾燥製剤
JP3242924B2 (ja) 調製済みのアゾセミド（ａｚｏｓｅｍｉｄｅ）注射液
AU2008256949A1 (en) Multi-dose concentrate esmolol with benzyl alcohol
WO2014007239A1 (ja) アムホテリシンｂ含有組成物

Legal Events

Date Code Title Description
N231 Notification of change of applicant
A201 Request for examination
N231 Notification of change of applicant
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20131218

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20141230

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20151217

Year of fee payment: 6

FPAY Annual fee payment

Payment date: 20161220

Year of fee payment: 7

FPAY Annual fee payment

Payment date: 20171219

Year of fee payment: 8

FPAY Annual fee payment

Payment date: 20181226

Year of fee payment: 9

FPAY Annual fee payment

Payment date: 20191217

Year of fee payment: 10